COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Lanièce Delaunay, Charlotte Martínez-Baz, Iván Sève, Noémie Domegan, Lisa Mazagatos, Clara Buda, Silke Meijer, Adam Kislaya, Irina Pascu, Catalina Carnahan, AnnaSara
Lanièce Delaunay, Charlotte
Martínez-Baz, Iván
Sève, Noémie
Domegan, Lisa
Mazagatos, Clara
Buda, Silke
Meijer, Adam
Kislaya, Irina
Pascu, Catalina
Carnahan, AnnaSara
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2024-03-28
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Translated Title
Published in
Euro Surveill 2024;29(13):pii2300403